Homology Medicines Inc (FIXX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt FIXX? Forum Prognose

Warum fällt Homology Medicines Inc-Aktie (FIXX)?

Wir haben während der Handelssitzung 2026-08-21 einen Rückgang der Aktie Homology Medicines Inc (FIXX) um 100.00% festgestellt. Obwohl dies auf normale Volatilität oder verschiedene interne und externe Faktoren zurückzuführen sein kann, beachten Sie bitte, dass wir die Situation aktiv beobachten und so schnell wie möglich zeitnahe Updates bereitstellen!

2023-11-16:

Homology Medicines Stock (FIXX) dropped by 34.99% from $0.8799 to $0.572 in the trading on Thursday November 16, 2023. The reasons why FIXX stock down today is due to the merger deal with Q32 Bio. Gene therapy companies Homology Medicines (FIXX) and Q32 Bio announced today that they have agreed to merge in an all-stock deal. The combined entity will be named Q32 Bio and will focus on Q32 Bio's experimental drugs for autoimmune and inflammatory diseases.

Homology Medicines shareholders will own approximately 25% of the combined entity, while Q32 Bio shareholders will own the rest.
FIXX investors will also be eligible for a contingent value right (CVR) related to sales of Homology Medicines' pre-merger assets.
The merger transaction is expected to close in Q1 2024.

RPRX

$61.31

1.21%

INSM

$125.77

0.55%

BNTX

$116.57

5.12%

ALNY

$236.22

3.02%

ONC

$374.47

1.44%

RVMD

$209.46

1.07%

Homology Medicines Inc (FIXX)

Warum fällt Homology Medicines Inc-Aktie (FIXX)?

Ähnlich wie FIXX